Apr 12, 2024, 08:19 AM by

DNAnexus announced that its ongoing collaboration with UK Biobank will be recognized with the 2024 Innovative Best Practices Global Impact Award at the upcoming Bio-IT World Conference and Expo.

Apr 12, 2024, 08:19 AM by

Apr 12, 2024, 08:19 AM by

Luma Lab Connect automatically centralizes, parses, and models data from lab instruments and other data sources for deeper analysis and insights on one harmonized, low-code cloud platform.

Apr 11, 2024, 10:33 AM by User Not Found

Bio-IT World | Molecular biologists at Iowa State University report the potential for the effects of genetic mutations to be known using a “super minigene” system developed in the lab of Ravindra Singh, Ph.D., professor of biomedical sciences.

Apr 11, 2024, 08:47 AM by

DNAnexus announced a collaboration with Oracle to advance precision health.

Apr 11, 2024, 08:47 AM by

ProPharma announces changes to its executive leadership team with strategic appointments to propel global growth

Apr 11, 2024, 08:47 AM by

Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms.

Apr 10, 2024, 08:21 AM by

Bios Health Group Unveils Bios Innovation Circle™ Groundbreaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena

Apr 10, 2024, 08:21 AM by

Apr 10, 2024, 06:00 AM by User Not Found

Bio-IT World | In drug discovery, the focus of machine learning and artificial intelligence tools has been on predicting outcomes without explanation or understanding of the biochemical pathways mediating those effects. But rigorous translation requires a solid science-based foundation to explain how a drug works, not just that it does.

Apr 9, 2024, 09:05 AM by

Apr 9, 2024, 09:05 AM by

Model Medicines has announced the upcoming release of two groundbreaking preprint papers on bioRxiv, detailing significant advances in antiviral and oncology drug discovery using their GALILEO AI platform. The first preprint reveals the discovery of a novel broad-spectrum antiviral target and inhibitor, while the second introduces ChemPrint, a deep learning model that achieved a remarkable 45.5% hit rate in identifying novel inhibitors of challenging oncology targets. These findings build upon Model Medicines' recent successes and underscore the transformative potential of their AI platform in revolutionizing drug discovery.

Apr 9, 2024, 09:05 AM by

CG Life is acquiring Toolhouse, doubling agency size and strengthening expertise in creating impactful digital experiences connecting with clinical and patient audiences.

Apr 9, 2024, 09:05 AM by

Tome Biosciences, Inc., the programmable genomic integration (PGI) company, today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office. This patent further protects Tome’s foundational PGI technology, integrase-mediated PGI (I-PGI), describes a system capable of performing I-PGI in a mammalian cell, and is exclusively licensed to Tome from MIT.

Apr 9, 2024, 09:05 AM by

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

Apr 9, 2024, 06:00 AM by User Not Found

Bio-IT World | During the NVIDIA GTC conference held at the San Jose Convention Center and online March 18-21, NVIDIA CEO Jensen Huang highlighted an array of advancements, including new foundation models coming to NVIDIA BioNeMo, a collaboration with Johnson & Johnson MedTech to expand AI’s role in surgical settings, and the launch of over two dozen generative AI microservices to advance areas like digital health, medical technology, and drug discovery.

Apr 8, 2024, 06:00 AM by User Not Found

Bio-IT World | Bio-IT World announced the 2024 Best of Show Finalists and People’s Choice Contenders today, highlighting 26 new products from 27 different companies that will be on display at the Bio-IT World Conference and Expo, April 15-17, in Boston. The Best of Show Awards will honor several new products live at the event during the Best of Show Awards Reception beginning at 5:15 on Tuesday, April 16.

Apr 5, 2024, 08:07 AM by

New MyPhenome test delivers patients and providers with the most comprehensive and actionable insights yet into their obesity type(s).

Apr 5, 2024, 08:07 AM by

Andaman7 Launches AI Supercharged Personal Health Record v5 New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.

Apr 5, 2024, 06:00 AM by User Not Found

Bio-IT World | The pace at which CRISPR has transitioned from a research tool to a therapeutic modality is remarkable. Initially targeting genetic diseases, CRISPR holds tremendous promise across various indications, rapidly expanding into oncology and infectious diseases, indicating CRISPR's vast and continual evolution as a modality.